Business profile & competitive position
Equifax Inc. is a global data, analytics, and technology company. Despite being classified under the Industrials sector and Consulting Services industry in the platform’s snapshot, its operations center on information solutions: credit, employment, income, education, fraud, healthcare licensure, and business data, delivered with analytics, artificial intelligence, machine learning, and proprietary software tools. It reports through three segments—Workforce Solutions, U.S. Information Solutions (USIS), and International—and also provides human-resources business process automation and outsourcing services for employers.
The company’s competitive position can be read partly through its margin and return figures. A net margin of 10.7% and an ROE of 15.0% suggest the business earns an above-average return on shareholder equity and retains reasonable pricing power despite operating in data-intensive markets. Its largest client accounted for only around 3% of total revenue, which points to a diversified revenue base across mortgage, financial services, government, automotive, insurance, healthcare, telecommunications, and other verticals. A key operational asset is The Work Number®, which held about 209 million active employment records and 813 million total employment records at December 31, 2025. That scale creates switching costs for lenders, employers, and government users who rely on verified employment and income data, and it is difficult for smaller competitors to replicate quickly.
Financial posture
Equifax currently trades at a market capitalization of $19.9 billion, with a trailing P/E ratio of 29.6. That valuation sits at a premium to many Industrials names, reflecting the company’s data-and-analytics profile and recurring revenue streams rather than a pure consulting business. Profitability is supported by a 10.7% net margin and a 15.0% ROE, both of which indicate the company converts revenue into bottom-line earnings and shareholder returns efficiently. The stock’s beta is 1.30, meaning it has historically moved more sharply, in percentage terms, than the overall equity market.
As of the latest snapshot, the share price was $169.795, with the 50-day exponential moving average at $178.22 and RSI at 38.5. That combination shows the stock trading below its recent moving average but not yet deeply oversold. The P/E of 29.6, alongside double-digit ROE, frames Equifax as a quality compounder priced at a level that assumes continued execution rather than deep value. The data did not include debt, cash, or leverage figures, so any view of the balance sheet should be confirmed from the most recent quarterly filing before drawing conclusions on financial risk.
Strategic priorities & outlook
Equifax’s most recent 10-K filing outlines four operational priorities that guide its near-term roadmap. First, it intends to leverage Equifax Cloud capabilities to accelerate innovation, new product development, and growth. Second, it plans to leverage and expand differentiated data assets and analytics through organic growth, acquisitions, and partnerships. Third, management emphasizes a customer- and consumer-first culture centered on speed, flexibility, stability, and performance. Fourth, the company expects to execute strategic, accretive acquisitions that expand data capabilities and drive revenue growth.
Together, these priorities suggest the business is trying to move faster on product launches while widening its data moat through both internal development and M&A. The 10-K also notes that international clients contributed 23% of total revenue in 2025, 24% in 2024, and 23% in 2023, so roughly three-quarters of revenue remains domestic. The stable international mix implies that the company is not making a sudden push into emerging markets, but it still derives meaningful revenue outside the U.S. and must manage cross-border data and compliance regimes. The focus on The Work Number® and cloud infrastructure suggests Workforce Solutions and USIS remain the core engines, while acquisitions are likely to target smaller data providers or vertical analytics capabilities.
Macro & geopolitical exposure
As a provider of credit and employment information, Equifax sits at the intersection of consumer finance, labor markets, housing, and corporate credit demand. Its classification as Industrials / Consulting Services is technically where the ticker lands, but its actual economic sensitivities are to interest rates, mortgage origination volumes, hiring activity, and business credit expansion. When rates rise and mortgage refinancing slows, activity in USIS tends to fall; when hiring accelerates, demand for employment verifications through Workforce Solutions tends to rise.
The company also has direct and indirect exposure to data privacy and cybersecurity regulation, both domestically and abroad. Its international revenue base means it must navigate varying rules around consumer consent, data localization, and breach notification. Trade policy and tariffs do not directly affect Equifax in the same way they affect manufacturers, but they can influence the credit health of the small-business and corporate clients that use Equifax services. Currency risk is present as roughly a quarter of revenue is generated internationally, though the recent mix has been stable. The September 14, 2026 headline on Canadian businesses carrying more debt as tariffs and payment stress deepen is a reminder that macro credit conditions in North America feed directly into the type of analytics and risk products Equifax sells.
Recent developments
Recent news flow has centered on both institutional ownership shifts and macro commentary. On September 14, 2026, GlobeNewswire reported that Canadian businesses are carrying more debt as tariffs and payment stress deepen, a macro signal relevant to Equifax’s credit and risk analytics verticals. On September 10, 2026, Defense World reported that the California State Teachers Retirement System acquired 30,587,555 shares of Equifax, while Amundi lowered its stock position in the company the same day. These opposing institutional moves highlight ongoing debate among large asset managers about current positioning.
On September 9, 2026, Zacks ran a piece headlined “Equifax (EFX) is a Top-Ranked Value Stock: Should You Buy?” The headline itself should not be read as a recommendation; rather, it reflects a quantitatively attractive ranking from that provider at the time. The news did not include a material operational update or product announcement, so the recent narrative is dominated by macro credit concerns and ownership rotation rather than a fundamental business event.
Earnings behavior & post-earnings drift
Equifax has beaten earnings expectations in 6 of the last 8 reported quarters, which is a 75% beat rate, and the average earnings surprise across those quarters was 3.9%. The average 5-day price move after earnings over that period was 1%, classified as an “up” drift direction. That modest positive drift suggests that, on average, the market has not fully repriced the stock within one day and some follow-through has occurred over the week following results.
Looking at the last four quarters, the post-earnings price reaction has been far more volatile than the headline average implies. On July 21, 2026, the company reported $2.25 in EPS against a $2.20 estimate, a 2.3% beat. The stock fell 1.47% the next day but then drifted 8.1% higher over the next five trading days. On April 21, 2026, Equifax beat by a much wider margin—$1.86 actual versus $1.69 estimate, a 10.1% surprise—but the market sold the stock off sharply: down 7.15% the next day and down 10.76% over the following five days. On February 4, 2026, a $2.09 report against $2.06 estimate, a 1.5% beat, produced a 5.51% next-day gain and a 9.15% five-day drift. On October 21, 2025, actual EPS was $2.04 versus estimate $1.94, a 5.2% beat, with a muted 0.31% next-day move and a 5-day drift of negative 2.51%.
What stands out is that the size of the EPS beat is not reliably correlated with the direction or magnitude of the price response. The April 2026 report had the largest beat and the worst post-earnings reaction, while the February 2026 report had the smallest beat and one of the strongest upward drifts. That pattern hints that the market’s real expectation may include factors beyond the headline EPS number—such as guidance, segment margins, mortgage-market commentary, or data-sales momentum. For the next report scheduled for October 20, 2026 before the market open, the consensus EPS estimate is $2.21. Traders watching this report should keep in mind both the 75% historical beat rate and the wide dispersion in post-results price behavior.
For a deeper dive, readers may want to examine the full institutional verdict on Equifax, including updated analyst estimate revisions, rating distributions, and forward guidance commentary, to complement the figures above.
Frequently Asked Questions
What does Equifax actually do?
Equifax is a global data, analytics, and technology company that sells information solutions to businesses, governments, and consumers. It operates through three segments—Workforce Solutions, U.S. Information Solutions, and International—and also provides human-resources business process automation and outsourcing services.
How has Equifax historically performed around earnings?
Over the last eight reported quarters, Equifax beat consensus EPS 75% of the time with an average surprise of 3.9%. The average five-day price move following those reports was 1% higher, although individual reactions have varied widely, including a 10.1% beat in April 2026 that was followed by a 10.76% five-day decline.
What are Equifax’s main strategic priorities?
According to its most recent 10-K, Equifax is focused on leveraging Equifax Cloud capabilities, expanding differentiated data assets and analytics through organic growth plus M&A, building a customer- and consumer-first culture, and executing accretive acquisitions that expand data capabilities.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-21 | $2.25 | $2.2 | +2.3% | -1.47% | +8.1% |
| 2026-04-21 | $1.86 | $1.69 | +10.1% | -7.15% | -10.76% |
| 2026-02-04 | $2.09 | $2.06 | +1.5% | +5.51% | +9.15% |
| 2025-10-21 | $2.04 | $1.94 | +5.2% | +0.31% | -2.51% |
| 2025-07-22 | $2 | $1.93 | +3.6% | - | - |
| 2025-04-22 | $1.53 | $1.41 | +8.5% | - | - |
Previous EFX editions
Get the institutional verdict on EFX
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the EFX verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.